Cargando…

Regulatory Status of Cannabidiol in the United States: A Perspective

Cannabidiol (CBD) is 1 of > 100 cannabinoids found in Cannabis sativa L. (Cannabis spp. or Cannabis). Despite its complex and rapidly evolving regulatory status in the United States, projected retail sales of CBD products—hemp, cannabis and pharmaceutical—are as high as $1.9 billion by 2020. CBD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Corroon, Jamie, Kight, Rod
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc., publishers 2018
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154432/ https://www.ncbi.nlm.nih.gov/pubmed/30283822 http://dx.doi.org/10.1089/can.2018.0030

Ejemplares similares

A Cross-Sectional Study of Cannabidiol Users
por: Corroon, Jamie, et al.
Publicado: (2018)

The pharmacology and therapeutic role of cannabidiol in diabetes
por: Zhang, Jin, et al.
Publicado: (2023)

Health Status of Visitors and Temporary Residents, United States
por: Yanni, Emad A., et al.
Publicado: (2009)

Targeting cannabidiol to specific areas of the brain: an ultrasound-based strategy
por: Branca, Jacopo Junio Valerio, et al.
Publicado: (2020)

Cannabidiol preferentially binds TRPV2: a novel mechanism of action
por: Landucci, Elisa, et al.
Publicado: (2022)

Current status of advanced gastrointestinal endoscopy training fellowships in the United States
por: Heller, Stephen J, et al.
Publicado: (2011)

Pandemic Influenza Planning in the United States from a Health Disparities Perspective
por: Blumenshine, Philip, et al.
Publicado: (2008)

We are what we eat: Regulatory gaps in the United States that put our health at risk
por: Maffini, Maricel V., et al.
Publicado: (2017)

A Conversion of Oral Cannabidiol to Delta9-Tetrahydrocannabinol Seems Not to Occur in Humans
por: Nahler, Gerhard, et al.
Publicado: (2017)

Perspective: The Convergence of Coronavirus Disease 2019 (COVID-19) and Food Insecurity in the United States
por: Nagata, Jason M, et al.
Publicado: (2020)

Development and Regulation of Novel Influenza Virus Vaccines: A United States Young Scientist Perspective
por: Khurana, Surender
Publicado: (2018)

Perspectives on an alternative career path in regulatory science
por: Fields, F. Owen
Publicado: (2013)

Quantitative Systems Pharmacology: A Regulatory Perspective on Translation
por: Zineh, Issam
Publicado: (2019)

How did “flatten the curve” become “flatten the economy?” A perspective from the United States of America
por: Jenson, Hal B.
Publicado: (2020)

Current status of university-based energy institutes in the United States and a pathway to forming a national organization
por: Whitacre, Jay F., et al.
Publicado: (2022)

Perspectives on statistical strategies for the regulatory biomarker qualification process
por: Hendrix, Suzanne B, et al.
Publicado: (2021)

Trends in Internet Searches for Cannabidiol (CBD) in the United States
por: Leas, Eric C., et al.
Publicado: (2019)

Quantitative Modeling and Simulation in PMDA: A Japanese Regulatory Perspective
por: Sato, M, et al.
Publicado: (2017)

A regulatory perspective on recombinant collagen-based medical devices
por: Liu, Wenbo, et al.
Publicado: (2021)

Vaccine Preparedness for the Next Influenza Pandemic: A Regulatory Perspective
por: Baylor, Norman W., et al.
Publicado: (2022)

The (in)visible Brazilians: A perspective review on the need for brain health and dementia research with Brazilian immigrants in the United States
por: Simon, Sharon Sanz, et al.
Publicado: (2023)

Norovirus Disease in the United States
por: Hall, Aron J., et al.
Publicado: (2013)

Normalizing the dementia status in cardiovascular diseases: a perspective
por: Frisardi, Vincenza
Publicado: (2022)

Perspective: Improving Nutritional Guidelines for Sustainable Health Policies: Current Status and Perspectives
por: Magni, Paolo, et al.
Publicado: (2017)

Creating Data Standards to Support the Electronic Transmission of Compounded Nonsterile Preparations (CNSPs): Perspectives of a United States Pharmacopeia Expert Panel
por: Parrish, Richard H., et al.
Publicado: (2022)

COVID-19 and the current state of palliative care in the United States
por: Sina-Odunsi, Ayobami Jadesola, et al.
Publicado: (2022)

Mounting antiscience aggression in the United States
por: Hotez, Peter J.
Publicado: (2021)

On-chip physiological mimicry of neurovascular unit: challenges and perspectives
por: Ahn, Song Ih, et al.
Publicado: (2023)

The changing risk and burden of wildfire in the United States
por: Burke, Marshall, et al.
Publicado: (2021)

Comparison of Lyme Disease in the United States and Europe
por: Marques, Adriana R., et al.
Publicado: (2021)

Considering Sun Safety Policies in the United States
por: Mirza, Fatima N., et al.
Publicado: (2023)

Perspective on the State of Pharmacometrics and Systems Pharmacology Integration
por: Trame, Mirjam N., et al.
Publicado: (2018)

Perspective on the current state of the LRRK2 field
por: Taymans, Jean-Marc, et al.
Publicado: (2023)

Hematopoietic stem cell mobilization: current status and future perspective
por: Kim, Jin Seok
Publicado: (2017)

Perspective: improving vitamin D status in the management of COVID-19
por: Ebadi, Maryam, et al.
Publicado: (2020)

Current status and perspectives of conversion therapy for advanced gastric cancer
por: Yang, Heli, et al.
Publicado: (2022)

Promoting Safe Early Clinical Research of Novel Drug Candidates: A European Union Regulatory Perspective
por: Ponzano, Stefano, et al.
Publicado: (2017)

Salmonella Enteritidis Infections, United States, 1985–1999
por: Patrick, Mary E., et al.
Publicado: (2004)

Physician‐scientists in the United States at 2020: Trends and concerns
por: Garrison, Howard H., et al.
Publicado: (2022)

Buying Time: The AMR Action Fund and the State of Antibiotic Development in the United States 2020
por: Clancy, Cornelius J, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bb13h23sl5seghmbjbvqnesolh